Compounds and uses thereof in modulating amyloid beta
US7781442B2 · kind B2 · utility
17Cited by
53References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 17, 2007 |
| Grant date | Aug 24, 2010 |
| Priority date | — |
| Expiry date | Jan 13, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel compounds, compositions, and kits are provided. Methods of modulating Aβ levels, and methods of treating a disease associated with aberrant Aβ levels are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.